MEDICAMEN BIOTECH LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 ,inter alia, to consider and approve Audited Financial Results (Standalone & Consolidated) for the quarter & year ended on 31.03.2024 and to approve Final Dividend for the FY 2023-24.

pdf

Medicamen Biotech Ltd.

26 Apr 2024

306.30

1.81%

Company Update

MEDICAMEN BIOTECH LTD.-$ - 531146 - Announcement Under Regulation 30 Of SEBI LODR Regulations, 2015

BSE India

Completion of USFDA Inspection at the Oncology Formulation Facility at Haridwar-Unit II

pdf

Medicamen Biotech Ltd.

24 Apr 2024

306.30

1.81%

Company Update

MEDICAMEN BIOTECH LTD.-$ - 531146 - Declaration Under Regulation 31 (4) Of The Securities And Exchange …

BSE India

Declaration under Regulation 31 (4) of the Securities and Exchange Board of India ( Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the financial year ended on March 31, 2024

pdf

Medicamen Biotech Ltd.

17 Apr 2024

306.30

1.81%

Company Update

MEDICAMEN BIOTECH LTD.-$ - 531146 - Certificate Pursuant To Regulation 40(9) Of The SEBI (LODR) Regulations, …

BSE India

Certificate pursuant to Regulation 40 (9) of the SEBI (LODR) Regulations, 2015

pdf

Medicamen Biotech Ltd.

17 Apr 2024

306.30

1.81%

Company Update

MEDICAMEN BIOTECH LTD.-$ - 531146 - Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR) Regulations, …

BSE India

Compliance certificate under Regulation 7 (3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 for the financial year ended as on March 31, 2024

pdf